USE OF ANTIBODIES AGAINST FLT-1 FOR THE TREATMENT OF OSTEOPOROSIS
Details for Australian Patent Application No. 2003251729 (hide)
International Classifications
Event Publications
16 October 2003 Complete Application Filed
Priority application(s): 02077591.2 28.06.02 EP
4 March 2004 Application Open to Public Inspection
Published as AU-A-2003251729
21 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
18 August 2005 Corrigenda
Applications OPI - Name Index Under the name VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW, Application No. 2003251729, under INID (71) correct the name to read K.U.LEUVEN RESEARCH & DEVELOPMENT; VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003251730-Bafilomycin-like metabolite from a novel Micromonospora species
2003251728-PLACENTAL GROWTH FACTOR AS A TARGET FOR THE TREATMENT OF OSTEOPOROSIS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser